Godmorgen

]]>https://dev.proinvestor.com/forum/topic/399170/genmab-marts-2023RSS for NodeMon, 08 Jun 2026 07:59:20 GMTWed, 01 Mar 2023 04:15:55 GMT60end of month & quarter. 4th red month in a row.

• • • 28/2 18:07
      af E L
      3rd red month in a row. Since the lows of 2011 we only once had 4 negative months in a row, at the end of 2017

]]>https://dev.proinvestor.com/forum/post/7662109https://dev.proinvestor.com/forum/post/7662109Fri, 31 Mar 2023 13:06:29 GMTNå mon vi skal have et positivt udfald af voldgift før 3000 kan brydes og agere ny bund. NPV impact er signifikant større på udfaldet af den afgørelse end af epco. Så bliver rart at komme på den anden side af retssagen. At få reduceret usikkerheden der tynger

]]>https://dev.proinvestor.com/forum/post/7662107https://dev.proinvestor.com/forum/post/7662107Fri, 31 Mar 2023 12:49:06 GMTAMGEN on Horizon acquisition: We believe that our decades of leadership in inflammation and nephrology, combined with our global presence and world-class biologic capabilities, will enable us to reach many more patients with life-changing medicines like TAVNEOS and TEPEZZA than either company could achieve on its own. https://www.amgen.com/stories/2023/03/2022-letter-to-shareholders

]]>https://dev.proinvestor.com/forum/post/7662110https://dev.proinvestor.com/forum/post/7662110Fri, 31 Mar 2023 06:46:42 GMThttps://onkologisktidsskrift.dk/behandlinger/lungekraeft/2835-nye-data-for-rybrevant-bekraefter-stoffets-potentiale-mod-egfr-exon-20-muteret-nsclc.html Nye data for Rybrevant bekræfter stoffets potentiale mod EGFR exon 20-muteret NSCLC

]]>https://dev.proinvestor.com/forum/post/7662108https://dev.proinvestor.com/forum/post/7662108Fri, 31 Mar 2023 06:43:19 GMTMorn, Fibonacci købssignal https://www.proinvestor.com/boards/111776/

]]>https://dev.proinvestor.com/forum/post/7662105https://dev.proinvestor.com/forum/post/7662105Fri, 31 Mar 2023 04:49:42 GMTDaratumumab, an anti-CD38 effective in two cases of severe refractory myositis https://www.institut-myologie.org/en/2023/03/30/daratumumab-an-anti-cd38-effective-in-two-cases-of-severe-refractory-myositis/

]]>https://dev.proinvestor.com/forum/post/7662101https://dev.proinvestor.com/forum/post/7662101Fri, 31 Mar 2023 04:38:29 GMThttps://twitter.com/tnewsomdavis/status/1641480986746662913 "Very surprised that 1/3 of audience opted
for 1L Amivantamab"

]]>https://dev.proinvestor.com/forum/post/7662104https://dev.proinvestor.com/forum/post/7662104Fri, 31 Mar 2023 04:25:09 GMTIn partnership with Roche/Genentech though

]]>https://dev.proinvestor.com/forum/post/7662100https://dev.proinvestor.com/forum/post/7662100Thu, 30 Mar 2023 14:28:28 GMTCorrect

]]>https://dev.proinvestor.com/forum/post/7662103https://dev.proinvestor.com/forum/post/7662103Thu, 30 Mar 2023 13:39:55 GMTVenetoclax is also from AbbVie if i am not mistaken...

]]>https://dev.proinvestor.com/forum/post/7662106https://dev.proinvestor.com/forum/post/7662106Thu, 30 Mar 2023 13:26:20 GMTDet er i vores mørkeste øjeblikke, at vi skal fokusere for at se lyset.

]]>https://dev.proinvestor.com/forum/post/7662099https://dev.proinvestor.com/forum/post/7662099Thu, 30 Mar 2023 13:10:30 GMTRigtig spændende med combi med venetoclax, som er et fantastisk stof. Det kan der komme noget stort ud af for Genmab/Abbvie og patienterne.

]]>https://dev.proinvestor.com/forum/post/7662097https://dev.proinvestor.com/forum/post/7662097Thu, 30 Mar 2023 13:02:58 GMTAmivantamab efficacy in pretreated NSCLC with EGFR Exon 20 insertion mutations persists long term https://dailyreporter.esmo.org/european-lung-cancer-congress-2023/elcc-2023/amivantamab-efficacy-in-pretreated-nsclc-with-egfr-exon-20-insertion-mutations-persists-long-term

]]>https://dev.proinvestor.com/forum/post/7662102https://dev.proinvestor.com/forum/post/7662102Thu, 30 Mar 2023 12:45:58 GMTinteresting, a new Epcoritamab trial +Venetoclax by the Haemato Oncology Foundation in the Netherlands, with Nordic & German CLL Study Groups, don't see genmab or abbvie - Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLL (AETHER) https://clinicaltrials.gov/ct2/show/NCT05791409

]]>https://dev.proinvestor.com/forum/post/7662096https://dev.proinvestor.com/forum/post/7662096Thu, 30 Mar 2023 11:59:44 GMTDen optur, der startede 10. marts synes sat lidt på pause. Håber på lidt positivt nyt, der kan give fornyede kræfter.

]]>https://dev.proinvestor.com/forum/post/7662095https://dev.proinvestor.com/forum/post/7662095Thu, 30 Mar 2023 08:56:34 GMTJa måske

]]>https://dev.proinvestor.com/forum/post/7662098https://dev.proinvestor.com/forum/post/7662098Thu, 30 Mar 2023 08:53:52 GMTMåske vag fordi de skal præsentere data senere?

]]>https://dev.proinvestor.com/forum/post/7662094https://dev.proinvestor.com/forum/post/7662094Thu, 30 Mar 2023 08:42:02 GMTBOLT også ude med vag PR på deres HER2 ISAC https://investors.boltbio.com/news-releases/news-release-details/bolt-biotherapeutics-announces-positive-topline-data-bdc-1001

]]>https://dev.proinvestor.com/forum/post/7662090https://dev.proinvestor.com/forum/post/7662090Thu, 30 Mar 2023 07:41:28 GMTThe collaboration with Genmab exploring Boltbody ISACs using Genmab’s proprietary bispecific antibodies accounted for $4.2 million in revenue for 2022

]]>https://dev.proinvestor.com/forum/post/7662091https://dev.proinvestor.com/forum/post/7662091Thu, 30 Mar 2023 06:57:38 GMTCollaborations with Genmab and Innovent developing next-generation Boltbody ISACs continue to progress. Both collaborations are exploring proprietary linker-payloads from the Boltbody ISAC platform, combining with Genmab’s proprietary bispecific
antibodies

]]>https://dev.proinvestor.com/forum/post/7662092https://dev.proinvestor.com/forum/post/7662092Thu, 30 Mar 2023 06:57:20 GMTBolt Biotherapeutics Reports Fourth Quarter and Full Year 2022 https://www.biospace.com/article/releases/bolt-biotherapeutics-reports-fourth-quarter-and-full-year-2022-financial-results-and-provides-business-update/

]]>https://dev.proinvestor.com/forum/post/7662093https://dev.proinvestor.com/forum/post/7662093Thu, 30 Mar 2023 06:55:41 GMTSådan , nok mange dansker der har det problem:-)

]]>https://dev.proinvestor.com/forum/post/7662088https://dev.proinvestor.com/forum/post/7662088Thu, 30 Mar 2023 06:12:31 GMT@Riis7. Jeg har ikke plads til flere Novo i pensionsdepoterne. Og de har ligget der, stille og roligt, i mange år

]]>https://dev.proinvestor.com/forum/post/7662089https://dev.proinvestor.com/forum/post/7662089Thu, 30 Mar 2023 05:45:56 GMThttps://www.euroinvestor.dk/nyheder/dansk-topledelse-faar-aktieenheder-for-77-millioner

]]>https://dev.proinvestor.com/forum/post/7662083https://dev.proinvestor.com/forum/post/7662083Thu, 30 Mar 2023 03:15:51 GMT